H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and babies: Study

Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and their babies, researchers at UT Southwestern Medical Center have found in a retrospective study of 239 cases of women who received the medications during pregnancy.

28 Apr 2010

3M first-quarter worldwide sales up 25% to $6.3 billion

3M today reported first-quarter earnings of $1.29 per share on sales of $6.3 billion. Operating income margins were 22.8 percent, up 7 percentage points year-on-year. Sales and per-share earnings increased 24.7 percent and 74.3 percent, respectively, versus the first quarter of 2009.

27 Apr 2010

Energizer Holdings reports 6% increase in second-quarter 2010 net sales

Energizer Holdings, Inc., today announced results of its second quarter ended March 31, 2010. Net earnings for the quarter were $88.5 million, or $1.25 per diluted share, versus net earnings of $77.0 million, or $1.30 per diluted share in the second fiscal quarter of 2009.

27 Apr 2010

Nanoviricides become registered trademark under USPTO

NanoViricides, Inc., announced today that the mark "nanoviricides" has now become a registered trademark under the US Patents and Trademarks Office. The mark was entered into the "principal register" of trademarks at the USPTO on April 20, 2010.

26 Apr 2010

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.

26 Apr 2010

Toddler dies after seasonal flu shot – health authorities on alert

Last Friday, Australia's Chief Medical Officer Professor Jim Bishop had announced his decision to suspend free seasonal flu vaccinations after more than 20 under-five kids mainly in Western Australia developed reactions to the shots. They developed fever, vomiting and convulsions. One of the children was reported to be severely ill.

25 Apr 2010

1976 "swine flu" vaccine protects against 2009 pandemic H1N1 influenza virus

New evidence shows immunization against "swine flu" in 1976 might provide individuals with some protection against the 2009 pandemic H1N1 influenza virus, according to new research from St. Jude investigators.

24 Apr 2010

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

"A year after the emergence of swine flu [H1N1], U.S. health authorities and laboratories say the pandemic illustrated the need for new vaccine production techniques that are faster and more reliable," Agence France-Presse writes in an article that examines the challenges associated with current vaccine development practices and plans for future development.

24 Apr 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.

From Baxter International Inc. 22 Apr 2010

Swine flu vaccine blues

Exactly a year after the swine flu outbreak vigilance, newer vaccine techniques and other measures are being emphasized by researchers and key decision makers. Dr. Harvey Fineberg, chairman of the World Health Organization's pandemic review committee and President of the U.S. Institute of Medicine says, we need to look at the past to learn from it.

22 Apr 2010

H1N1 flu epidemic has lessons to offer health care providers: Anesthesia Progress

The H1N1 flu epidemic has lessons to offer health care providers. The limited amount of vaccine available initially left pregnant women, small children with medical conditions, and other high-risk populations waiting in long lines. The problems encountered in reaching certain segments of the population apply to the provision of dental care as well as other disciplines.

22 Apr 2010

AFP reflects on WHO's response to H1N1

Agence France-Presse examines the WHO's response to H1N1 (swine flu) one year since the virus was first reported in Mexico and the U.S. "A year on, questions linger as to whether a decision by the World Health Organization to declare swine flu a pandemic, thereby unleashing the slew of health measures, was over-dramatic or even tainted by commercial interests," the news service writes.

22 Apr 2010

Test shows efficacy of avian antibodies against H5N1 and H1N1 influenza in mice

Scientists have discovered for the first time that antibodies in common eggs laid by hens vaccinated against the H5N1 virus can potentially prevent a possible H5N1 pandemic, raising the possibility that the same principle could be applied to the current H1N1 influenza pandemic.

21 Apr 2010

Pregnant women face increased risk of death from H1N1; early antiviral treatment associated with fewer complications

Pregnant women had a disproportionately higher risk of death due to 2009 influenza A(H1N1) in the U.S., and early antiviral treatment appeared to be associated with fewer admissions to an ICU and fewer deaths, according to a study in the April 21 issue of JAMA.

21 Apr 2010

UnitedHealth Group's consolidated first-quarter 2010 revenues increase 5% to $23.2 billion

UnitedHealth Group today reported first quarter results, including better-than-projected membership and services growth and effective cost management across its businesses. Financial metrics were in line with or better than Company expectations.

20 Apr 2010

Avian flu's endurance in 5 countries poses global threat to human health, FAO official says

Though the world has made "great strides" in eliminating H5N1 (avian flu) from poultry since the "peak of its outbreak in 2006" in 63 countries, the virus persists in Bangladesh, China, Egypt, Indonesia and Vietnam, VOA News reports (DeCapua, 4/16).

20 Apr 2010

Pharmacists Mutual Insurance selects Interactive Intelligence's CIC to support employees

Pharmacists Mutual Insurance Company has selected the Interactive Intelligence all-in-one IP communications software suite, Customer Interaction Center, to support its on-site and branch office employees.

20 Apr 2010

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

The National Vaccine Information Center participated in a meeting sponsored by the federal National Vaccine Advisory Committee and facilitated by The Keystone Center April 11-13 in Salt Lake City to discuss strengthening the U.S. vaccine safety system.

17 Apr 2010

GeoViz methods help users visualize the pattern of how disease spreads

Disease statistics buried within patient records or detailed in newspaper clippings can be sorted and organized to depict geographic patterns, allowing the discovery of trends that were previously overlooked, according to a Penn State geographer.

16 Apr 2010

Idaho Technology receives USASMDC contract to develop flu tests for military personnel

Idaho Technology, Inc. has been awarded a contract by the U.S. Army Space and Missile Defense Command (USASMDC) to develop tests for multiple flu strains on the Joint Biological Agent Identification and Diagnostic System (JBAIDS).

16 Apr 2010

H1N1 News and Research

Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and babies: Study

3M first-quarter worldwide sales up 25% to $6.3 billion

Energizer Holdings reports 6% increase in second-quarter 2010 net sales

Nanoviricides become registered trademark under USPTO

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

Toddler dies after seasonal flu shot – health authorities on alert

1976 "swine flu" vaccine protects against 2009 pandemic H1N1 influenza virus

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Swine flu vaccine blues

H1N1 flu epidemic has lessons to offer health care providers: Anesthesia Progress

AFP reflects on WHO's response to H1N1

Test shows efficacy of avian antibodies against H5N1 and H1N1 influenza in mice

Pregnant women face increased risk of death from H1N1; early antiviral treatment associated with fewer complications

UnitedHealth Group's consolidated first-quarter 2010 revenues increase 5% to $23.2 billion

Avian flu's endurance in 5 countries poses global threat to human health, FAO official says

Pharmacists Mutual Insurance selects Interactive Intelligence's CIC to support employees

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

GeoViz methods help users visualize the pattern of how disease spreads

Idaho Technology receives USASMDC contract to develop flu tests for military personnel

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News